Accessibility Menu
 
Genprex logo

Genprex

(NASDAQ) GNPX

Current Price$1.86
Market Cap$4.36M
Since IPO (2018)-100%
5 Year-100%
1 Year-90%
1 Month+1%

Genprex Financials at a Glance

Market Cap

$4.36M

Revenue (TTM)

$0.00

Net Income (TTM)

$16.77M

EPS (TTM)

$-47.66

P/E Ratio

-0.04

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$1.86

Volume

252,798

Open

$1.94

Previous Close

$1.88

Daily Range

$1.83 - $1.96

52-Week Range

$1.71 - $55.00

GNPX News

No articles available.

GNPX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genprex

Industry

Biotechnology

Employees

15

CEO

Ryan M. Confer

Headquarters

Austin, TX 78746, US

GNPX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-1379%

Return on Capital

-16%

Return on Assets

-5%

Earnings Yield

-25.00%

Dividend Yield

0.00%

Payout Ratio

-16.53%

Stock Overview

Market Cap

$4.36M

Shares Outstanding

2.32M

Volume

252.80K

Short Interest

0.00%

Avg. Volume

1.03M

Financials (TTM)

Gross Profit

$6.69K

Operating Income

$21.17M

EBITDA

$21.10M

Operating Cash Flow

$17.15M

Capital Expenditure

$0.00

Free Cash Flow

$17.15M

Cash & ST Invst.

$1.60M

Total Debt

$0.00

Genprex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.36M

N/A

Market Cap/Employee

$290.63K

N/A

Employees

15

N/A

Net Income

$3.80M

+12.0%

EBITDA

$3.80M

+11.9%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$1.10M

-25.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.71%

N/A

Return on Invested Capital

-16.16%

N/A

Free Cash Flow

$3.19M

-125.7%

Operating Cash Flow

$3.19M

-125.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIMNLiminatus Pharma, Inc. Class A Common Stock
$0.21+5.63%
TOVXTheriva Biologics, Inc.
$0.19+4.36%
INMInMed Pharmaceuticals Inc.
$0.82-0.29%
CNSPCNS Pharmaceuticals, Inc.
$2.29+5.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About GNPX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.